River Front Investment Group, LLC Abbott Laboratories Transaction History
River Front Investment Group, LLC
- $4.15 Billion
- Q3 2024
A detailed history of River Front Investment Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, River Front Investment Group, LLC holds 11,789 shares of ABT stock, worth $1.51 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,789
Previous 9,408
25.31%
Holding current value
$1.51 Million
Previous $977,000
37.56%
% of portfolio
0.03%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,224Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$21.5 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.81 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.41 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.82 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...